Revive Therapeutics

Psychedelics in Japan: Dr. Hiroyuki Uchida on Studies, Stigma, and the Road AheadMay 21, 2025
As global interest in psychedelic therapies grows, Japan is beginning to chart its own path, grounded in cultural nuance, regulatory caution, and scientific rigour. In this interview, Dr. Hiroyuki Uchida of Keio University discusses his journey into psychedelic research, the challenges of launching Japan’s first psilocybin trials, and the steps being taken to ensure a safe, culturally appropriate psychedelic future.
FDA’s Makary Hints at Faster Reviews for Psychedelic TherapiesMay 19, 2025
In a brief interview on Friday, FDA Commissioner Marty Makary publicly addressed psychedelic therapies for the first time in his new role, floating the potential for expedited reviews. While he emphasised urgency, he stopped short of outlining any concrete policy changes. Here, we cover the interview and provide our analysis.
Pα+ Psychedelic Bulletin #197: Portuguese Health-Related Professions Unite on Psychedelics; Shrooms, Shots, and the Next Surgeon General; Religious Leaders Study Set to PublishMay 16, 2025
Bridging Promise and Prudence: Portuguese Health-Related Professions Unite to Release First National Guidelines on Psychedelic Therapy • Shrooms, Shots, and the Next Surgeon General: Psychedelics at the Centre of MAGA Infighting • ‘No One Has the Right to Speak for Us’: Religious Leaders Who Participated in Hopkins Study Push Back on Critics As Publication Nears • Manvir Singh Challenges the Stories Westerners Tell About Psychedelics’ Past • Compass Pathways Sets Expectations Ahead of June Readout • and more...
The Interdisciplinary Annotated Psychedelic Research Bibliography of 2024May 14, 2025
Psychedelic Alpha’s Medical Advisor, Michael Haichin, compiled a list of over 500 notable psychedelics-related publications from 2024. He then presented it to a group of researchers from varying disciplines, asking for their comments on the papers that they found most intriguing. Here, we present the list along with their comments as our inaugural Interdisciplinary Annotated Psychedelic Research Bibliography.
Spring 2025 Psychedelic Policy Update: Bills Hang in the Balance as Legislative Sessions Wind DownMay 13, 2025
As spring legislative sessions wind down across the country, some state lawmakers are racing to pass a diverse wave of psychedelic-related bills. From Colorado’s upcoming data collection system to New Mexico’s landmark psilocybin access law and Texas’ flurry of psychedelic-related efforts, here’s a state-by-state look at the major developments… and where the clock may run out.

Revive Therapeutics

Latest News

Revive Therapeutics Announces Initiation of Novel Bucillamine Formulation Development

Revive Therapeutics Announces Filing of Patent for Bucillamine in the Treatment of Exposure to Chemical Warfare Agents

Revive Therapeutics Announces Results of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Revive Therapeutics Announces Data Safety Monitoring Board Meeting Date on Phase 3 Clinical Study of Bucillamine in the Treatment of COVID-19

Revive Therapeutics Advances MDMA Transdermal Patch Development with Purchase of MDMA Supply from PharmAla Biotech

Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder

Join our Newsletter

Psychedelic Alpha

Quick Links

Newsletter

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights